Anastasia Dmitriyevna Safontseva

Anastasia Dmitriyevna Safontseva

Auto-generated profile, based on publicly available information

Anastasia Dmitriyevna Safontseva

Kuban State Medical University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2024 in Cytokines and inflammation
Verified
Journal Article
Open access
PDF file
INIrina Vadimovna Nesterova
Irina Vadimovna Nesterova
SKSvetlana Valentinovna Kovaleva
Svetlana Valentinovna Kovaleva
GCGalina Anatolyevna Chudilova
Galina Anatolyevna Chudilova
EPElisey Andreyevich Poezzhaev
Elisey Andreyevich Poezzhaev
APAnna Ivanovna Pirogova
Anna Ivanovna Pirogova
ASAnastasia Dmitriyevna Safontseva
Anastasia Dmitriyevna Safontseva
Despite significant advancements in extending average life expectancy, challenges persist in enhancing the quality of life for elderly and senile individuals, preventing and treating age-associated diseases and managing geriatric syndromes. The immune system plays a crucial role in aging, undergoing extensive functional changes collectively referred to as immunosenescence. Cellular aging within the immune system is associated with telomere shortening, proteostasis loss, mitochondrial dysfunction, DNA damage, and oxidative stress. Senescent cells are characterized by resistance to apoptosis, cell cycle arrest, and abnormal production of pro-inflammatory cytokines, leading to chronic low-grade inflammation. Concurrently, the effector mechanisms of the immune response become depleted, resulting in a reduced ability of the immune system to adequately respond to antigenic stimuli. Thymic atrophy, depletion of bone marrow niches, a shift in hematopoiesis toward the myeloid lineage, and alterations in lymphocyte subpopulation ratios occur. Additionally, the effector functions of neutrophil granulocytes are impaired. However, the nature of these functional changes in immunosenescence remains insufficiently studied, requiring further research to determine the specific dysfunctions of neutrophil granulocytes in aging.

28 September 2025 in Russian Journal of Immunology
Verified
Journal Article
Open access
PDF file
INIrina V. Nesterova
Irina V. Nesterova
GCGalina A. Chudilova
Galina A. Chudilova
ASAnastasia D. Safontseva
Anastasia D. Safontseva
VCValeriya N. Chapurina
Valeriya N. Chapurina
DLDarina E. Lyagusha
Darina E. Lyagusha
NBNatusya K. Barova
Natusya K. Barova
Dysfunction of neutrophilic granulocytes (NG) is a decisive factor in the development and progression of atypical purulent-inflammatory diseases, including acute destructive pneumonia (ADP) in children. A promising approach is to include immunocorrective therapy in complex treatment, thus promoting recovery of NG functions. The objective of this study was to assess the features of defective NG functioning associated with changes in relative contents and phenotype of CD16+CD62L+CD11b+CD63- and CD16+CD62L+CD11b+CD63+ neutrophil subsets in children with ADP, to evaluate clinical and immunological effectiveness of immunomodulatory therapy in complex postoperative treatment using a pharmaceutical drug with a synthetic thymic hexapeptide (pdHP) being the active substance. The study included 21 children aged 2-4 years: with a diagnosis of ADP (study group, SG) before complex treatment, and a group after treatment with hexapeptide (SG1). The comparison group included 20 conditionally healthy children (CG), Twenty children treated for ADP comprised the archival comparison group (aCG). The functions of NG were assessed by the content of CD16+CD62L+CD11b+CD63- and CD16+CD62L+CD11b+CD63+ subsets using FC500 (Beckman Coulter) device. We also determined indices characterizing phagocytosis (%PAN, PN, PI, %D, ID), NADPH oxidase activity (%PPC, MCI) in the NBT test. We have found a phenotypic transformation of physiological subset to CD16dimCD62LdimCD11bbrightCD63- NG with defective immune properties, a 3-fold increase in the content of NG subset with hyperactivated phenotype CD16brightCD62LbrightCD11bbrightCD63bright (p 0.05), a defect in phagocytic function, but increased oxidase activity (p1, 2 0.05) in immunocompromised children with ADP. After complex treatment with the inclusion of hexapeptide, we observed normalization of NG effector functions associated with phenotype remodeling and restoration of the subpopulation ratio. Positive clinical dynamics was revealed when compared with aCG children receiving conventional therapy, i.e., a significant reduction in fever duration (|δ| = 0.98), respiratory failure (|δ| = 0.99), more rapid regression of pleural effusion (|δ| = 0.96) and early removal of drainages (|δ| = 1.00). The obtained results indicate a pronounced positive clinical and immunological efficiency of pdHP usage in complex treatment of children with ADP.

29 October 2026 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
INI. V. Nesterova
I. V. Nesterova
GCG. A. Chudilova
G. A. Chudilova
NBN. K. Barova
N. K. Barova
ASA. D. Safontseva
A. D. Safontseva
EPE. A. Poezzhaev
E. A. Poezzhaev
ДЛД. Э. Лягуша
Д. Э. Лягуша
The multiple functions of neutrophilic granulocytes (NG) are associated with various subsets and phenotypes of these cells. Previously, in children with severe purulent inflammatory diseases, a correlation was found between the severity of disease and contents of CD66b + CD16 + CD33 + HLA-DR + NG (APC-NG) subset. Thus, the determination of the APC-NG subset may serve as a valuable diagnostic tool and an efficiency index during complex therapy in severe purulent-inflammatory diseases. Our goal was to assess the dynamic changes in APC-NG levels in children with AHO in comparison with the dynamics of indicators of clinical effectiveness during immunomodulatory therapy with a synthetic thymic hexapeptide (HP). Materials and methods. The study group (SG) included 15 children aged 10-15 years with acute hematogenic osteomyelitis (AHO), the comparison group (CG) consisted of 13 conditionally healthy children. The contents of NG expressing CD66b, CD16, CD33, HLA-DR (FC500, Beckman Coulter), and expression density of these molecules was evaluated in peripheral blood (PB) of patients and controls. The PB samples were collected before surgery, on the 10 th day of therapy, and before discharge. The immunological parameters of control samples were studied once. The amounts of APC-NG were found to be increased by 18 times in study group before treatment, being decreased by 1.9 times on the 10 th day after the beginning of treatment, and by 3.8 times at the time of discharge (20-25 th day). However, the content of APC-NG after treatment did not reach the CG levels. Moreover, a decreased number of APC-NG correlated with positive clinical dynamics: there was an earlier regression of general and local symptoms. A delay in positive changes of APC-NG was observed in the absence of clinical efficiency, thus requiring a revision of therapeutic strategy, and changes of antibacterial therapy. Conclusion: The study demonstrated high clinical efficacy of thymic HP in the complex treatment of children with AHO and a diagnostic potential of the APC-NG contents as a diagnostic marker for monitoring efficacy of postsurgical treatment of pediatric AHO patients. This marker may also serve as a tool that allows for timely correction of AHO treatment at the in- and outpatient stages.